Clinical Trial Update: HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating HSV-tk gene therapy with Valacyclovir in combination with brachytherapy for recurrent prostate cancer; currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HSV-tk gene therapy
• Valacyclovir (Valacyclovir)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: RECRUITING